|
1
|
Lehrer S, Green S, Ramanathan L,
Rosenzweig K and Labombardi V: No consistent relationship of
glioblastoma incidence and cytomegalovirus seropositivity in
whites, blacks, and Hispanics. Anticancer Res. 32:1113–1115.
2012.PubMed/NCBI
|
|
2
|
Hu Y, Lin X, Wang P, Xue YX, Li Z, Liu LB,
Yu B, Feng TD and Liu YH: CRM197 in combination with shRNA
interference of VCAM-1 displays enhanced inhibitory effects on
human glioblastoma cells. J Cell Physiol. 220:1713–1728. 2015.
View Article : Google Scholar
|
|
3
|
Stupp R, Hegi ME, Mason WP, van den Bent
MJ, Taphoorn MJ, Janzer RC, Ludwin SK, Allgeier A, Fisher B,
Belanger K, et al: Effects of radiotherapy with concomitant and
adjuvant temozolomide versus radiotherapy alone on survival in
glioblastoma in a randomised phase III study: 5-year analysis of
the EORTC-NCIC trial. Lancet Oncol. 10:459–466. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Oberoi RK, Parrish KE, Sio TT, Mittapalli
RK, Elmquist WF and Sarkaria JN: Strategies to improve delivery of
anticancer drugs across the blood-brain barrier to treat
glioblastoma. Neuro Oncol. 18:27–36. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Jiang WG, Sanders AJ, Katoh M, Ungefroren
H, Gieseler F, Prince M, Thompson SK, Zollo M, Spano D, Dhawan P,
et al: Tissue invasion and metastasis: Molecular, biological and
clinical perspectives. Semin Cancer Biol. 35:(Suppl). S244–S275.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Scott RW, Crighton D and Olson MF:
Modeling and imaging 3-dimensional collective cell invasion. J Vis
Exp pii. 35252011.
|
|
7
|
Yang J and Weinberg RA:
Epithelial-mesenchymal transition: At the crossroads of development
and tumor metastasis. Dev Cell. 14:818–829. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kalluri R and Weinberg RA: The basics of
epithelial-mesenchymal transition. J Clin Invest. 119:1420–1428.
2009. View
Article : Google Scholar : PubMed/NCBI
|
|
9
|
Li L and Li W: Epithelial-mesenchymal
transition in human cancer: Comprehensive reprogramming of
metabolism, epigenetics, and differentiation. Pharmacol Ther.
150:33–46. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Lim J and Thiery JP:
Epithelial-mesenchymal transitions: Insights from development.
Development. 139:3471–3486. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lamouille S, Xu J and Derynck R: Molecular
mechanisms of epithelial-mesenchymal transition. Nat Rev Mol Cell
Biol. 15:178–196. 2014. View
Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zang M, Zhang B, Zhang Y, Li J, Su L, Zhu
Z, Gu Q, Liu B and Yan M: CEACAM6 promotes gastric cancer invasion
and metastasis by inducing epithelial-mesenchymal transition via
PI3K/AKT signaling pathway. PLoS One. 9:e1129082014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Lo JF, Yu CC, Chiou SH, Huang CY, Jan CI,
Lin SC, Liu CJ, Hu WY and Yu YH: The epithelial-mesenchymal
transition mediator S100A4 maintains cancer-initiating cells in
head and neck cancers. Cancer Res. 71:1912–1923. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Blick T, Hugo H, Widodo E, Pinto C, Mani
SA, Weinberg RA, Neve RM, Lenburg ME and Thompson EW: Epithelial
mesenchymal transition traits in human breast cancer cell lines
parallel the CD44(hi/)CD24 (lo/−) stem cell phenotype in human
breast cancer. J Mammary Gland Biol Neoplasia. 15:235–252. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kubicek S, O'Sullivan RJ, August EM,
Hickey ER, Zhang Q, Teodoro ML, Rea S, Mechtler K, Kowalski JA,
Homon CA, et al: Reversal of H3K9me2 by a small-molecule inhibitor
for the G9a histone methyltransferase. Mol Cell. 25:473–481. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Fan JD, Lei PJ, Zheng JY, Wang X, Li S,
Liu H, He YL, Wang ZN, Wei G, Zhang X, et al: The selective
activation of p53 target genes regulated by SMYD2 in BIX-01294
induced autophagy-related cell death. PLoS One. 10:e01167822015.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kim Y, Kim YS, Kim DE, Lee JS, Song JH,
Kim HG, Cho DH, Jeong SY, Jin DH, Jang SJ, et al: BIX-01294 induces
autophagy-associated cell death via EHMT2/G9a dysfunction and
intracellular reactive oxygen species production. Autophagy.
9:2126–2139. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Schmittgen TD, Zakrajsek BA, Mills AG,
Gorn V, Singer MJ and Reed MW: Quantitative reverse
transcription-polymerase chain reaction to study mRNA decay:
Comparison of endpoint and real-time methods. Anal Biochem.
285:194–204. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Dheda K, Huggett JF, Bustin SA, Johnson
MA, Rook G and Zumla A: Validation of housekeeping genes for
normalizing RNA expression in real-time PCR. Biotechniques.
37:112–114. 2004.PubMed/NCBI
|
|
20
|
Uekita T, Tanaka M, Takigahira M, Miyazawa
Y, Nakanishi Y, Kanai Y, Yanagihara K and Sakai R:
CUB-domain-containing protein 1 regulates peritoneal dissemination
of gastric scirrhous carcinoma. Am J Pathol. 172:1729–1739. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Koukourakis MI, Kalamida D, Giatromanolaki
A, Zois CE, Sivridis E, Pouliliou S, Mitrakas A, Gatter KC and
Harris AL: Autophagosome proteins LC3A, LC3B and LC3C have distinct
subcellular distribution kinetics and expression in cancer cell
lines. PLos One. 10:e01376752015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wu Y and Zhou BP: New insights of
epithelial-mesenchymal transition in cancer metastasis. Acta
Biochim Biophys Sin (Shanghai). 40:643–650. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Auffinger B, Tobias AL, Han Y, Lee G, Guo
D, Dey M, Lesniak MS and Ahmed AU: Conversion of differentiated
cancer cells into cancer stem-like cells in a glioblastoma model
after primary chemotherapy. Cell Death Differ. 21:1119–1131. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Chintala SK, Tonn JC and Rao JS: Matrix
metalloproteinases and their biological function in human gliomas.
Int J Dev Neurosci. 17:495–502. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Schwartzbaum JA, Fisher JL, Aldape KD and
Wrensch M: Epidemiology and molecular pathology of glioma. Nat Clin
Pract Neurol. 2:494–503. 2006.quiz 1 p following 516. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Omuro A and DeAngelis LM: Glioblastoma and
other malignant gliomas: A clinical review. Jama. 310:1842–1850.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Lee JM, Dedhar S, Kalluri R and Thompson
EW: The epithelial-mesenchymal transition: New insights in
signaling, development, and disease. J Cell Biol. 172:973–981.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Singh A and Settleman J: EMT, cancer stem
cells and drug resistance: An emerging axis of evil in the war on
cancer. Oncogene. 29:4741–4751. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Osorio LA, Farfán NM, Castellón EA and
Contreras HR: SNAIL transcription factor increases the motility and
invasive capacity of prostate cancer cells. Mol Med Rep.
13:778–786. 2016.PubMed/NCBI
|
|
30
|
Chow AK, Ng L, Lam CS, Wong SK, Wan TM,
Cheng NS, Yau TC, Poon RT and Pang RW: The Enhanced metastatic
potential of hepatocellular carcinoma (HCC) cells with sorafenib
resistance. PloS One. 8:e786752013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Colak S and Medema JP: Cancer stem
cells-important players in tumor therapy resistance. FEBS J.
281:4779–4791. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Reya T, Morrison SJ, Clarke MF and
Weissman IL: Stem cells, cancer and cancer stem cells. Nature.
414:105–111. 2001. View
Article : Google Scholar : PubMed/NCBI
|
|
33
|
Wang XQ, Ng RK, Ming X, Zhang W, Chen L,
Chu AC, Pang R, Lo CM, Tsao SW, Liu X, et al: Epigenetic regulation
of pluripotent genes mediates stem cell features in human
hepatocellular carcinoma and cancer cell lines. PloS One.
8:e724352013. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Zhou Y, Hofstetter WL, He Y, Hu W, Pataer
A, Wang L, Wang J, Zhou Y, Yu L, Fang B and Swisher SG: KLF4
inhibition of lung cancer cell invasion by suppression of SPARC
expression. Cancer Biol Ther. 9:507–513. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Han L, Shi S, Gong T, Zhang Z and Sun X:
Cancer stem cells: Therapeutic implications and perspectives in
cancer therapy. Acta Pharmaceutica Sinica B. 3:65–75. 2013.
View Article : Google Scholar
|
